Wall Street's Record-Setting First Week: What the 'January Effect' Signals for 2026
The S&P 500 and Dow closed at all-time highs to cap the first full trading week of 2026. Historical patterns suggest this bodes well for the year ahead.
1312 articles found for "investing"
America's Pharmacy Desert Crisis: Why 1,200 Walgreens Closures Are Just the Beginning
As Walgreens closes 1,200 stores and Rite Aid winds down entirely, millions of Americans face growing 'pharmacy deserts' with diminishing access to essential medications.
Constellation Brands Beats Q3 Estimates as Beer Margins Defy Volume Pressures
Constellation Brands reports $3.06 EPS, beating estimates by $0.43, as Modelo and Corona brands deliver strong margins despite industry-wide volume challenges.
Tesla Deliveries Plunge 16% in Q4: What the Second Straight Year of Decline Means for Investors
Tesla delivered 418,227 vehicles in Q4 2025, down 16% year-over-year, as the EV maker faces mounting competition and a post-tax credit hangover.
Intel Surges 10% After CEO Lip-Bu Tan's White House Meeting Cements 'Made in America' Chip Strategy
Intel stock jumps 10% as CEO Lip-Bu Tan meets with President Trump at the White House, doubling the value of the U.S. government's stake in the chipmaker.
Dollar Rebounds From 8-Year Low: Why the Greenback Is Staging a 2026 Comeback
The US Dollar Index has climbed toward 99 after its biggest annual decline since 2017. Here's what's driving the greenback's early 2026 rebound and what it means for investors.
The 4.2% Problem: Why Rising Treasury Yields Are the Biggest Risk to 2026's Rally
The 10-year Treasury yield has climbed to 4.2%, the highest since December 2025. Here's why bond market dynamics could derail the stock market's strong start to 2026.
Saks Fifth Avenue Teeters on the Brink: Luxury Retail Giant Eyes Sunday Bankruptcy Filing
Saks Global is preparing to file for Chapter 11 bankruptcy as soon as Sunday after failing to secure $1 billion in financing. The 158-year-old luxury retailer faces liquidation risk.
OneStream Goes Private: Hg's $6.4 Billion Bet on Enterprise Finance Software
Private equity firm Hg is taking OneStream private just 18 months after its IPO, betting $6.4 billion that AI will transform enterprise finance software.
Merck Eyes $32 Billion Revolution Medicines Takeover: The Keytruda Replacement Race Intensifies
Merck is in advanced talks to acquire Revolution Medicines for up to $32 billion as it races to replace blockbuster cancer drug Keytruda before patent expiration.
JPMorgan Takes the Reins: Apple Card's $20 Billion Move Reshapes Credit Card Industry
JPMorgan Chase has reached a deal to acquire the Apple Card from Goldman Sachs, marking a major shift in consumer finance and ending Goldman's costly retail experiment.
Johnson & Johnson Joins TrumpRx: Pharma Giant Trades Drug Price Cuts for Tariff Relief
Johnson & Johnson has agreed to cut drug prices for Americans in exchange for tariff exemptions, joining nine other pharmaceutical giants in the Trump administration's TrumpRx.gov initiative.